Literature DB >> 24135843

Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.

Angela Lupattelli1, Olav Spigset, Gideon Koren, Hedvig Nordeng.   

Abstract

This study aimed to examine obstetric bleeding outcomes after exposure during pregnancy to selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic (TCAs), and other antidepressants (OADs).The Norwegian Mother and Child Cohort Study and the Medical Birth Registry of Norway constituted the data source for the present study. We included 57,279 pregnant women, of which 1.02% reported use of antidepressants during pregnancy, mostly SSRIs/SNRIs (0.92%). We categorized exposure according to antidepressant use in pregnancy (SSRIs/SNRIs, n = 527; TCAs/OADs, n = 59; nonexposed, nondepressed, n = 55,411) with inclusion of a disease comparison group (nonexposed, depressed, n = 1282). We used logistic regression to estimate adjusted odds ratio (aOR) and 95% confidence interval (CI) for vaginal bleeding outcomes in pregnancy and postpartum hemorrhage.Compared with nonexposed subjects, first trimester exposure to SSRIs/SNRIs or TCAs/OADs did not confer any increased risk of vaginal bleeding in early pregnancy (aOR, 0.91; 95% CI, 0.72-1.16 and aOR, 0.83; 95% CI, 0.36-1.92, respectively). No increased risk for vaginal bleeding in midpregnancy was observed among users of SSRIs/SNRIs (aOR, 0.81; 95% CI, 0.50-1.31) or TCAs/OADs (aOR, 0.96; 95% CI, 0.26-3.53) in second trimester. Exposure to SSRIs/SNRIs during gestational week 30 to childbirth did not confer any increased risk of postpartum hemorrhage after vaginal (aOR, 0.90; 95% CI, 0.47-1.74) or cesarean (aOR, 1.47; 95% CI, 0.51-4.22) delivery. Women in the disease comparison group presented a significant moderate increased risk of vaginal bleeding in early pregnancy (aOR, 1.22; 95% CI, 1.06-1.39) and midpregnancy (aOR, 1.28; 95% CI, 1.07-1.55) but not postpartum.Among this Norwegian cohort of pregnant women, use of antidepressants in pregnancy was not associated with any obstetrical bleeding outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24135843     DOI: 10.1097/JCP.0000000000000036

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

1.  Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?

Authors:  Deborah R Kim; Emily Pinheiro; James F Luther; Heather F Eng; John L Dills; Stephen R Wisniewski; Katherine L Wisner
Journal:  J Psychiatr Res       Date:  2015-11-19       Impact factor: 4.791

Review 2.  Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.

Authors:  Lindsay G Lebin; Andrew M Novick
Journal:  Curr Psychiatry Rep       Date:  2022-10-01       Impact factor: 8.081

Review 3.  Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.

Authors:  Katharine Baratz Dalke; Amy Wenzel; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

4.  Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage.

Authors:  Kristin Palmsten; Christina D Chambers; Alan Wells; Gretchen Bandoli
Journal:  Paediatr Perinat Epidemiol       Date:  2020-03-24       Impact factor: 3.980

5.  Impact of Comorbidity and Prescription Drugs on Haemorrhage in Cholecystectomy.

Authors:  J Strömberg; G Sandblom
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

6.  Depression in pregnant and postpartum women during COVID-19 pandemic: systematic review and meta-analysis.

Authors:  Nicholas Adrianto; Josephine Caesarlia; Fegita Beatrix Pajala
Journal:  Obstet Gynecol Sci       Date:  2022-06-27

7.  Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study.

Authors:  Hanna M Heller; Anita C J Ravelli; Andrea H L Bruning; Christianne J M de Groot; Fedde Scheele; Maria G van Pampus; Adriaan Honig
Journal:  BMC Pregnancy Childbirth       Date:  2017-06-02       Impact factor: 3.007

8.  The importance of depression during pregnancy.

Authors:  Atefeh Ghanbari Khanghah; Zahra Bostani Khalesi; Rad Hassanzadeh
Journal:  JBRA Assist Reprod       Date:  2020-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.